36
MANAGEMENT OF ADOLESCENT CERVICAL PARAGANGLIOMA: 13 CASES FOUAD A.FOUAD Assistant professor of surgical oncology National Cancer Institute (NCI) Cairo University 07/03/2022 1 Fouad Abdelshaheed [NCI]

Cervical paraganglioma esso 32 slides 2 2012

Embed Size (px)

Citation preview

Page 1: Cervical paraganglioma esso 32 slides 2 2012

MANAGEMENT OF ADOLESCENT CERVICAL

PARAGANGLIOMA: 13 CASES

FOUAD A.FOUADAssistant professor of surgical oncology

National Cancer Institute (NCI)

Cairo University

04/14/2023 1Fouad Abdelshaheed [NCI]

Page 2: Cervical paraganglioma esso 32 slides 2 2012

INTRODUCTION

• A paraganglioma is a rare neuroendocrine tumor.

• 75% of paragangliomas are sporadic. • 25% are hereditary .• 90% adrenal (pheochromocytoma).• 10% extra-adrenal .

04/14/2023 2Fouad Abdelshaheed [NCI]

Page 3: Cervical paraganglioma esso 32 slides 2 2012

INTRODUCTION

• Extra-adrenal– 85% abdomen– 12% thorax– 3% head and neck:

• Carotid body most common(CBT)• Vagal(VP)• Jugulotympanic(JP;TP)• Other

• Cervical paragangliomas [CP] generally present in mid-adult life.

04/14/2023 3Fouad Abdelshaheed [NCI]

Page 4: Cervical paraganglioma esso 32 slides 2 2012

TREATMENT

• The different therapeutic options include:

Surgical resection. Conventional radiotherapy . Stereotactic radio surgery In selected cases a ‘wait and scan’ Foote RL,

et al.[2002]

04/14/2023 Fouad Abdelshaheed [NCI] 4

Page 5: Cervical paraganglioma esso 32 slides 2 2012

AIM OF THIS STUDY

• The aim to review our experience at NCI in management of cervical paraganglioma in the adolescent age as regard:

Surgical treatment Functional results.

04/14/2023 5Fouad Abdelshaheed [NCI]

Page 6: Cervical paraganglioma esso 32 slides 2 2012

MATERIAL AND METHODS

• During the period 2002–2011, thirteen patients with cervical paragangliomas have been presented to NCI, Cairo university for surgical treatment.

• All patients were adolescents with mean age 17.2 years (range, 13 to 21 years).

• Complete surgical resection was possible in all cases in this study

04/14/2023 6Fouad Abdelshaheed [NCI]

Page 7: Cervical paraganglioma esso 32 slides 2 2012

 PREOPERATIVE DATA

Percentage No; of the patients Item

84.6%:15.4% 11/2 Female/male

17.2±2.3 Mean Age(Years)

69.2%23%7.6%69.2%:30.8%

9/133/131/139:4

Main symptom: Lateral neck mass Mixed symtomatology Headache Lt. /Rt.

15.1±9.4 Duration of symptoms (mean in months)

23%53.1%23%

3/137/133/13

Size of the tumor >2 cm 2-4cm >4 cm

15.3% 2/13 Pre op. biopsy

04/14/2023 7Fouad Abdelshaheed [NCI]

Page 8: Cervical paraganglioma esso 32 slides 2 2012

Accidental pre-operative biopsy

04/14/2023 8Fouad Abdelshaheed [NCI]

Page 9: Cervical paraganglioma esso 32 slides 2 2012

04/14/2023 9Fouad Abdelshaheed [NCI]

Page 10: Cervical paraganglioma esso 32 slides 2 2012

Pre-operative investigation

• Ultrasonography (US) • Computerized tomography (CT)• Magnetic Resonance Imaging (MRI)

[seven out of 13 (53.8%) ]

• Digital subtraction angiography (DSA) {All cases}

• Balloon test occlusion (BTO) [three cases with large tumors more than 4 cm]

04/14/2023 10Fouad Abdelshaheed [NCI]

In all cases

Page 11: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 11

Page 12: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 12

Page 13: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 13

Page 14: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 14

Page 15: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 15

Page 16: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 16

Page 17: Cervical paraganglioma esso 32 slides 2 2012

04/14/2023 Fouad Abdelshaheed [NCI] 17

Page 18: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 18

Page 19: Cervical paraganglioma esso 32 slides 2 2012

CP-IMAGING

04/14/2023 Fouad Abdelshaheed [NCI] 19

Page 20: Cervical paraganglioma esso 32 slides 2 2012

Preoperative selective embolization

• Remains a matter of debate as major complications such as cerebrovascular accidents might occur.

• For some authors, allows safer surgical excision of the paraganglioma

• In our series, no patient underwent selective embolization

04/14/2023 Fouad Abdelshaheed [NCI] 20

Page 21: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

• Incision along the anterior border of the sternocleidomastoid

04/14/2023 Fouad Abdelshaheed [NCI] 21

Page 22: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

• Proximal exposure of the CCA.• The branches from the ECA were ligated

and divided near the tumor border . • The dissection was performed in the

relatively a vascular subadventitial plane between the artery and the tumor called “white line”.

04/14/2023 Fouad Abdelshaheed [NCI] 22

Page 23: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

04/14/2023 Fouad Abdelshaheed [NCI] 23

Page 24: Cervical paraganglioma esso 32 slides 2 2012

POST OPERATIVE SPECIMEN

04/14/2023 Fouad Abdelshaheed [NCI] 24

Page 25: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

04/14/2023 Fouad Abdelshaheed [NCI] 25

Page 26: Cervical paraganglioma esso 32 slides 2 2012

POST OPERATIVE SPECIMEN

04/14/2023 Fouad Abdelshaheed [NCI] 26

Page 27: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

04/14/2023 Fouad Abdelshaheed [NCI] 27

Page 28: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE TECHNIQUE

04/14/2023 Fouad Abdelshaheed [NCI] 28

Page 29: Cervical paraganglioma esso 32 slides 2 2012

POST OPERATIVE SPECIMEN

04/14/2023 Fouad Abdelshaheed [NCI] 29

Page 30: Cervical paraganglioma esso 32 slides 2 2012

OPERATIVE DATA

• The mean operative time was 84.7 ±36.4 ml minutes;

• Mean blood loss was 98.07±39 ml.• Mean size of the resected tumors was

3.6±1.5 cm (range 1.8–6.8 cm).

04/14/2023 Fouad Abdelshaheed [NCI] 30

Page 31: Cervical paraganglioma esso 32 slides 2 2012

POST-OPERATVE DIAGNOSIS

Percentage Number Type of the tumor

61.7% 8

2 [25%]5 [62.5]1 [12.5%]

CBTShamblin 1971 class:

• I [Localized] • II [Adherent Partially ]• III [Encasing]

23% 3 VP

15.3% 2 JP

04/14/2023 Fouad Abdelshaheed [NCI] 31

Page 32: Cervical paraganglioma esso 32 slides 2 2012

Vascular and neurological injuries

Cranial nerves injuries Carotid arteries injuries

Item

XII XI X IX ICA injury

ECA injury

2(15%) 1(7.6%) 3(23%) CBPs

3(23%) 1(7.6%) VPs

1(7.6%) 2(15.3%) JPs

04/14/2023 Fouad Abdelshaheed [NCI] 32

Page 33: Cervical paraganglioma esso 32 slides 2 2012

MORBIDITY AND MORTALITY

• Post operative difficulty in deglutition in 3 patients.

• No transient ischemic attack or stroke was noticed in any patient .

• No perioperative mortality was documented 

04/14/2023 Fouad Abdelshaheed [NCI] 33

Page 34: Cervical paraganglioma esso 32 slides 2 2012

CONCLUSION• Cervical paragangliomas in the adolescent

age are a rare entity • More predominant in females• Carotid body tumors are the most common

head and neck CP in adolescent age.• Best treated by proper surgical resection.

04/14/2023 Fouad Abdelshaheed [NCI] 34

Page 35: Cervical paraganglioma esso 32 slides 2 2012

CONCLUSION• Early management of patients and expert

surgeons minimize neurovascular complications

• Cranial nerve deficits were more common in patients with JP and VP relative to those with CBT but all improved rapidly in that young age.

04/14/2023 Fouad Abdelshaheed [NCI] 35

Page 36: Cervical paraganglioma esso 32 slides 2 2012

04/14/2023 Fouad Abdelshaheed [NCI] 36

THANK YOU